PL3452012T3 - Kompozycje do leczenia zespołu policystycznych jajników i powiązanych zaburzeń metabolicznych - Google Patents

Kompozycje do leczenia zespołu policystycznych jajników i powiązanych zaburzeń metabolicznych

Info

Publication number
PL3452012T3
PL3452012T3 PL17727376T PL17727376T PL3452012T3 PL 3452012 T3 PL3452012 T3 PL 3452012T3 PL 17727376 T PL17727376 T PL 17727376T PL 17727376 T PL17727376 T PL 17727376T PL 3452012 T3 PL3452012 T3 PL 3452012T3
Authority
PL
Poland
Prior art keywords
compositions
treatment
metabolic disorders
polycystic ovary
ovary syndrome
Prior art date
Application number
PL17727376T
Other languages
English (en)
Inventor
Bernard Fioretti
Lucio Leonardi
Original Assignee
S&R Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56555565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3452012(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by S&R Farmaceutici S.P.A. filed Critical S&R Farmaceutici S.P.A.
Publication of PL3452012T3 publication Critical patent/PL3452012T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL17727376T 2016-04-13 2017-04-13 Kompozycje do leczenia zespołu policystycznych jajników i powiązanych zaburzeń metabolicznych PL3452012T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITUA2016A002575A ITUA20162575A1 (it) 2016-04-13 2016-04-13 Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa
EP17727376.0A EP3452012B1 (en) 2016-04-13 2017-04-13 Compositions for treating polycystic ovary syndrome and related metabolic disorders
PCT/IB2017/052151 WO2017179012A1 (en) 2016-04-13 2017-04-13 Nutraceutical or pharmaceutical composition for use in the treatment of polycystic ovary syndrome or of diseases or disorders related thereto

Publications (1)

Publication Number Publication Date
PL3452012T3 true PL3452012T3 (pl) 2022-01-24

Family

ID=56555565

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17727376T PL3452012T3 (pl) 2016-04-13 2017-04-13 Kompozycje do leczenia zespołu policystycznych jajników i powiązanych zaburzeń metabolicznych

Country Status (7)

Country Link
US (2) US11246834B2 (pl)
EP (1) EP3452012B1 (pl)
ES (1) ES2890050T3 (pl)
HU (1) HUE055882T2 (pl)
IT (1) ITUA20162575A1 (pl)
PL (1) PL3452012T3 (pl)
WO (1) WO2017179012A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20162575A1 (it) 2016-04-13 2017-10-13 S&R Farm S P A Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa
CA3083301C (en) * 2017-11-23 2024-05-21 Biosearch, S.A. Method for increasing embryo implantation rate in a female subject suffering polycystic ovary syndrome
PL238919B1 (pl) * 2018-02-28 2021-10-18 Verco Spolka Akcyjna Kompozycja farmaceutyczna zawierająca mio-inozytol i D-chiro- inozytol, do zastosowania w terapeutycznym sposobie obniżania masy ciała u kobiet z zespołem policystycznych jajników
EP3810104B1 (en) 2018-04-16 2024-03-06 S&R Farmaceutici S.p.A. Mixture of resveratrol supported on magnesium hydroxide and non-supported pure resveratrol for treating female fertility
IT201800011155A1 (it) * 2018-12-17 2020-06-17 S&R Farm S P A uso di una miscela di berberina e resveratrolo per il controllo delle dislipidemie
WO2021053685A1 (en) * 2019-09-20 2021-03-25 Ramesh Patodia A novel nutraceutical formulation for polycystic ovary syndrome (pcos)
EP4000626A1 (en) * 2020-11-16 2022-05-25 concrete flowers GmbH Pharmaceutical preparation
IT202200025767A1 (it) * 2022-12-15 2024-06-15 Prolabin & Tefarm S R L Formulazione comprendente polifenoli vanilloidi supportati su solidi lamellari per ridurre i livelli plasmatici di CGRP e sue applicazioni.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040395A1 (it) 2004-08-03 2004-11-03 Sigma Tau Ind Farmaceuti Composizione comprendente statine e acidi grassi omega 3.
US20100129467A9 (en) 2007-08-31 2010-05-27 Albritton Iv Ford D Nutritional supplement
US8383165B1 (en) 2009-08-31 2013-02-26 Fairhaven Health, Llc Composition and method for fertility therapy using nutritional supplements
IT1404171B1 (it) * 2011-02-10 2013-11-15 Paladin Pharma S P A Composizione per l'uso nel trattamento dei problemi/disturbi della menopausa e nel trattamento dell'invecchiamento generale dell'organismo
US20130224281A1 (en) 2011-04-07 2013-08-29 United States Of America As Represented By The Administrator Of The National Aeronautics & Space Method and composition for ameliorating the effects for a subject exposed to radiation or other sources of oxidative stress
ITFI20110252A1 (it) * 2011-11-22 2013-05-23 Lo Li Pharma Srl Composizione farmaceutica comprendente myo-inositolo e d-chiro-inositolo.
ITPG20120030A1 (it) 2012-06-27 2013-12-29 Bernard Fioretti Resveratrolo inorganico ibrido
ITRM20130655A1 (it) * 2013-11-26 2015-05-27 Dicofarm Spa Prodotto a base di una associazione di glucomannano ed inositolo
IN2014MU01312A (pl) * 2014-04-09 2015-10-16 Olive Healthcare
ITUB20153066A1 (it) * 2015-08-11 2017-02-11 Graal S R L Composizione alimentare e/o nutraceutica contenente pea
ITUA20162575A1 (it) 2016-04-13 2017-10-13 S&R Farm S P A Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa
US10092545B2 (en) 2016-04-30 2018-10-09 Fairhaven Health, Llc Nutritional supplements for improving female fertility
EP3810104B1 (en) 2018-04-16 2024-03-06 S&R Farmaceutici S.p.A. Mixture of resveratrol supported on magnesium hydroxide and non-supported pure resveratrol for treating female fertility

Also Published As

Publication number Publication date
EP3452012B1 (en) 2021-06-23
US11246834B2 (en) 2022-02-15
HUE055882T2 (hu) 2021-12-28
EP3452012A1 (en) 2019-03-13
WO2017179012A1 (en) 2017-10-19
ES2890050T3 (es) 2022-01-17
US20190125675A1 (en) 2019-05-02
US20220395460A1 (en) 2022-12-15
ITUA20162575A1 (it) 2017-10-13

Similar Documents

Publication Publication Date Title
DK3889145T3 (da) 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme
LT3600270T (lt) Junginiai ir kompozicijos hematologiniams sutrikimams gydyti
DK3612215T3 (da) Sammensætninger til behandling af lungeinflammation
PL3452012T3 (pl) Kompozycje do leczenia zespołu policystycznych jajników i powiązanych zaburzeń metabolicznych
IL246833A0 (en) New salts and their pharmaceutical preparations for the treatment of inflammatory disorders
LT3250210T (lt) Kompozicijos ir būdai, skirti gydyti cns sutrikimus
EP3474820C0 (en) GLP-1 COMPOSITIONS AND ITS USES
IL255109A0 (en) New dihydropyridoisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
LT3224269T (lt) Kompozicijos ir būdai, skirti cns sutrikimams gydyti
DK3185876T3 (da) Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser
DK3212226T3 (da) Sammensætninger og anvendelsesfremgangsmåder til behandling af metaboliske lidelser
DK3102213T3 (da) Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser
PL3484469T3 (pl) Kompozycje i sposoby do wzmacniania działania środków przeciwdrobnoustrojowych
HUE055263T2 (hu) 11-Szubsztituált 24-hidroxiszterolok NMDA-hoz kapcsolódó állapotok kezelésére
EP3183005A4 (en) Methods and compositions for the treatment of metabolic disorders
IL262348A (en) Preparations for the treatment of excessive radiation disorders
DK3081263T3 (da) Sammensætninger og redskaber til behandling af glaukom
DK3524255T3 (da) Sammensætning til behandling af acne
IL275182A (en) Preparations and methods for the treatment of metabolic conditions
GB201411241D0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL258032A (en) Compounds and preparations for the treatment of ocular disorders
GB201401086D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
PL3373922T3 (pl) Kompozycje i sposoby do stosowania do leczenia homocystynurii
KR102502031B9 (ko) 체중 및 대사 증후군을 조절하기 위한 조성물 및 방법
PL3582796T3 (pl) Kompozycja do leczenia kaszlu